CoChat

Fecal Microbial Transplant Via Nasogastric Tube for Active Pediatric Ulcerative Colitis

Suskind, David L., Singh, Namita, Nielson, Heather, Wahbeh, Ghassan · 2015 · Journal of Pediatric Gastroenterology and Nutrition

The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Ulcerative colitis (UC), a chronic inflammatory disease of the large intestine, is characterized by a dysregulated immune reaction. UC is associated with fecal dysbiosis. Human and animal studies support the fact that the gastrointestinal microbiome may trigger the intestinal immune response, resulting in UC. Fecal microbial transplantation (FMT), by changing the gastrointestinal microbiome of patients with UC, may be a therapeutic option. METHODS: Four patients with moderate symptoms defined by the Pediatric Ulcerative Colitis Activity Index were enrolled in a prospective, open-label study of FMT via nasogastric tube in pediatric UC (US Food and Drug Administration IND 14942). After the donor and patient evaluation, patients received FMT with follow-up evaluations at 2, 6, and 12 weeks after transplantation. Study subjects were maintained on their pretransplant medications. The Pediatric Ulcerative Colitis Activity Index score, C-reactive protein, and stool calprotectin were completed during each study visit. RESULTS: Four patients with UC were enrolled (all boys). Ages ranged from 13 to 16 years. Patients tolerated FMT without adverse effects. None of the patients clinically improved with FMT, nor were there any significant changes in stool calprotectin or laboratory values, including C-reactive protein, albumin, and hematocrit. Three individuals received additional standard medical therapies before the end of the study. CONCLUSIONS: This study, although showing that single-dose FMT via nasogastric tube is well tolerated in active pediatric UC, did not show any clinical or laboratory benefit.

Overview

Integrity signals

Registry

Crossref · 10.1097/mpg.0000000000000544

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 13 references

Research works printed but not linked: 1

  1. Bauschlein M, 1997, Epilepsy, Kinderkrankenschwester, 16, 13

Cited by

See all 104

Metadata

Authors
Suskind, D. L., Singh, N., Nielson, H., & Wahbeh, G.
Affiliations
  • Seattle Children's Hospital (US)
  • Cedars-Sinai Medical Center (US)
Corresponding author
  • Suskind, David L.
  • Nielson, Heather
  • Wahbeh, Ghassan
Venue
Journal of Pediatric Gastroenterology and Nutrition
Publisher
Wiley
Published
2015-01
Volume
60
Issue
1
Pages
27-29
ISSN
  • 0277-2116 (ISSN-L)
  • 1536-4801
OpenAlex
W2321645834
Cited by
99
References
14
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 8 · 2020: 11 · 2019: 11 · 2018: 16 · 2017: 14 · 2016: 13 · 2015: 8
FWCI
7.86
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Pediatric Gastroenterology and Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
Keywords
fecal microbiota transplantation, pediatric ulcerative colitis, nasogastric tube administration, gut microbiota, calprotectin, C-reactive protein, tolerability, inflammatory bowel disease
MeSH terms
Adolescent, Anti-Inflammatory Agents, Non-Steroidal, Colitis, Ulcerative, Combined Modality Therapy, Feces, Follow-Up Studies, Hospitals, Pediatric, Humans, Immunosuppressive Agents, Intubation, Gastrointestinal, Male, Outpatient Clinics, Hospital, Severity of Illness Index, Washington, Probiotics, Therapies, Investigational, Donor Selection, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fecal Microbial Transplant Via Nasogastric Tube for Active Pediatric Ulcerative Colitis. https://app.cochat.ai/papers/10.1097/mpg.0000000000000544
The paper
Suskind, D. L., Singh, N., Nielson, H., & Wahbeh, G. (2015). Fecal Microbial Transplant Via Nasogastric Tube for Active Pediatric Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/mpg.0000000000000544

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.